Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
Phase 2
Withdrawn
- Conditions
- MelanomaMalignant Melanoma
- Interventions
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- NeoPlas Innovation
- Target Recruit Count
- 250
- Registration Number
- NCT00963664
- Locations
- 🇺🇸
NeoPlas Innovation, Nashville, Tennessee, United States
News
No news found